Literature DB >> 9489807

Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?

F De Benedetti, A Martini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489807

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  28 in total

Review 1.  The use of anakinra in juvenile arthritis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  Juvenile idiopathic arthritis: management and therapeutic options.

Authors:  Natasha M Ruth; Murray H Passo
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

3.  High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.

Authors:  Mikel Alberdi-Saugstrup; Marek Zak; Susan Nielsen; Troels Herlin; Ellen Nordal; Lillemor Berntson; Anders Fasth; Marite Rygg
Journal:  Rheumatol Int       Date:  2017-03-10       Impact factor: 2.631

Review 4.  Advances from clinical trials in juvenile idiopathic arthritis.

Authors:  Daniel J Lovell; Nicola Ruperto; Edward H Giannini; Alberto Martini
Journal:  Nat Rev Rheumatol       Date:  2013-07-09       Impact factor: 20.543

5.  Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).

Authors:  C M Hedrich; N Bruck; B Fiebig; M Gahr
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

Review 6.  Biologics in juvenile idiopathic arthritis: a narrative review.

Authors:  Federica Vanoni; Francesca Minoia; Clara Malattia
Journal:  Eur J Pediatr       Date:  2017-07-20       Impact factor: 3.183

7.  Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.

Authors:  Grant S Schulert; Shima Yasin; Brenna Carey; Claudia Chalk; Thuy Do; Andrew H Schapiro; Ammar Husami; Allen Watts; Hermine I Brunner; Jennifer Huggins; Elizabeth D Mellins; Esi M Morgan; Tracy Ting; Bruce C Trapnell; Kathryn A Wikenheiser-Brokamp; Christopher Towe; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2019-10-01       Impact factor: 10.995

8.  Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis.

Authors:  Troels Herlin
Journal:  Core Evid       Date:  2010-06-15

Review 9.  Systemic JIA: new developments in the understanding of the pathophysiology and therapy.

Authors:  Sebastiaan J Vastert; Wietse Kuis; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

10.  Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options.

Authors:  Ilaria Pagnini; Federico Bertini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.